NARA Discovery
Article Details
← Back to Search Results
Journal Article

Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells

Fengtao You; Licui Jiang; Bozhen Zhang; Qiang Lu; Qiao Zhou; Xiaoyang Liao; Hong Wu; Kaiqi Du; Youcai Zhu; Huimin Meng; Zhishu Gong; Yunhui Zong; Lei Huang; Man Lu; Jirong Tang; Yafen Li; Xiaochen Zhai; Xiangling Wang; Sisi Ye; Dan Chen; Lei Yuan; Lin Qi; Lin Yang
Science China Life Sciences · Vol. 59, Issue 4 · pp. 386-397 · 2016
View Full Text Download RIS Journal Homepage

Abstract

Abstract is unavailable.

Bibliographic Information

JournalScience China Life Sciences
PublisherSpringer
Publication Date2016-04-01
Publication Year2016
Volume59
Issue4
Pages386-397
Document TypeJournal Article
Print ISSN1674-7305
eISSN1869-1889
DOI10.1007/s11427-016-5024-7

Access Information

NARA Access Coverage1997-01-01~Current
Journal Homepagehttps://www.springer.com/journal/11427
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.